Skip to main content
Journal of Clinical Laboratory Analysis logoLink to Journal of Clinical Laboratory Analysis
. 2001 Jun 27;15(4):188–192. doi: 10.1002/jcla.1026

Asian multicenter trials on urinary type IV collagen in patients with diabetic nephropathy

Yasuhiko Tomino 1,, Shigenobu Suzuki 1, Chieko Azushima 1, Ichiyu Shou 1, Toshihiko Iijima 2, Mitsunori Yagame 3, Li Ning Wang 4, Hung‐Chun Chen 5, Kar‐Neng Lai 6, Si Yen Tan 7, Myung Jae Kim 8
PMCID: PMC6807741  PMID: 11436201

Abstract

To investigate the changes of renal type IV collagen turnover in diabetic nephropathy, urinary type IV collagen was measured by a highly sensitive one‐step sandwich enzyme immunoassay (EIA). Urinary samples were obtained from 698 diabetic patients and 191 healthy adults. Among the patients, 264 had urinary albumin levels of less than 29 mg/g·creatine (Cr) (Stage I: normoalbuminuric stage), 169 had microalbuminuria from 30 to 299 mg/g·Cr (Stage II: microalbuminuric stage), 84 patients had macroalbuminuria of more than 300 mg/g·Cr and serum Cr of less than 1.1 mg/dl (Stage IIIA: macroalbuminuric stage without renal dysfunction), 97 had macroalbuminuria of more than 300 mg/g·Cr and serum Cr of more than 1.2 mg/dl (Stage IIIB: macroalbuminuric stage with renal dysfunction), and 84 had renal failure (Stage IV). The levels of urinary type IV collagen in Stages II, IIIA, IIIB, and IV were significantly higher than those in Stage I (P < 0.0001). The level of urinary type IV collagen in Stage I (5.00 ± 0.23 μg/g·Cr; mean ± SE) was also higher than that in normal adults (3.44 ± 0.11 μg/g·Cr; mean ± SE). These levels increased gradually due to progression of the clinical stage of diabetic nephropathy. It appears that the levels of urinary type IV collagen can be a useful marker for detecting renal injuries in diabetes according to our Asian multicenter trials. J. Clin. Lab. Anal. 15:188–192, 2001. © 2001 Wiley‐Liss, Inc.

Keywords: urinary type IV collagen, diabetic nephropathy, Asian multicenter trials

REFERENCES

  • 1. Incidence by primary disease in 1999. 1999. In: An overview of regular dialysis treatment in Japan. Jpn Soc Dial Ther 817 (in Japanese).
  • 2. Mauer SM, Steffes MW, Ellis EN, Sutherland DER, Brown DM, Goetz FC. 1984. Structural–functional relationships in diabetic nephropathy. J Clin Invest 74:1143–1155. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3. Hogemann B, Balleisen L, Rauterberg J, Voss B, Gerlach U. 1986. Basement membrane components (7S collagen, laminin P1) are increased in sera of diabetic and activate platelets in vitro. Haemostasis 16:428–432. [DOI] [PubMed] [Google Scholar]
  • 4. Hayashi Y, Makino H, Ota Z. 1992. Serum and urinary concentrations of type IV collagen and laminin as a marker of microangiopathy in diabetes. Diabet Med 9:366–370. [DOI] [PubMed] [Google Scholar]
  • 5. Yagame M, Kim Y, Zhu D, Suzuki D, Eguchi K, Nomoto Y, Sakai H, Groppoli T, Steffes MW, Mauer SM. 1995. Differential distribution of type IV collagen chains in patients with diabetic nephropathy in non‐insulin‐dependent diabetes mellitus. Nephron 70:42–48. [DOI] [PubMed] [Google Scholar]
  • 6. Yagame M, Suzuki D, Jinde K, Saotome N, Sato H, Noguchi M, Sakai H, Kuramoto T, Sekizuka K, Iijima T, Suzuki S, Tomino Y. 1997. Significance of urinary type IV collagen in patients with diabetic nephropathy using a highly sensitive one‐step sandwich enzyme immunoassay. J Clin Lab Anal 11:110–116. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7. Iijima T, Suzuki S, Sekizuka K, Hishiki T, Yagame M, Jinde K, Saotome N, Suzuki D, Sakai H, Tomino Y. 1998. Follow‐up study on type IV collagen in patients with early stage diabetic nephropathy. J Clin Lab Anal 12:378–382. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8. Takizawa H, Satoh T, Kurusu A, Hishiki T, Shike T, Gohda T, Maeda A, Makita Y, Suzuki S, Fukui M, Tomino Y. 1998. Increase of urinary type IV collagen in normoalbuminuric patients with impaired glucose tolerance (IGT). Nephron 79:474–475. [DOI] [PubMed] [Google Scholar]
  • 9. Kuzuya N. 1970. Report of the committee of diagnostic criteria of diabetes mellitus by the glucose tolerance test. J Jpn Diab Soc 13:17–20. [Google Scholar]
  • 10. 1991. Stage classification of diabetic nephropathy In: Reports of Ministry of Health and Welfare Japan. Tokyo, Japan: Ministry of Health and Welfare; p 251–256 (in Japanese). [Google Scholar]
  • 11. Hashida S, Imagawa M, Inoue S, Ruan K‐H, Ishikawa E. 1984. More useful maleimide compounds for the conjugation of Fab′ to horseradish peroxide through thiol groups in the hinge. J Appl Biochem 6:56–63. [PubMed] [Google Scholar]
  • 12. Ishikawa E, Imagawa M, Hashida S, Hamaguchi Y, Ueno T. 1983. Enzyme‐labeling of antibodies and their fragments for enzyme immunoassay and immunohistochemical staining. J Immunoassay 4:209–327. [DOI] [PubMed] [Google Scholar]
  • 13. Bos ES, Van der Doelen AA, Rooy NV, Schuurs AHWM. 1981. 3,3′,5,5′‐Tetramethylbenzidine as an Ames test negative chromogen for horseradish peroxidase in enzyme‐immunoassay. J Immunoassay 2:187–204. [DOI] [PubMed] [Google Scholar]
  • 14. Obata K, Iwata K, Ichida T, Inoue K, Matsumoto E, Muragaki Y, Ooshima A. 1989. One step sandwich enzyme immunoassay for human type IV collagen using monoclonal antibodies. Clin Chim Acta 181:293–304. [DOI] [PubMed] [Google Scholar]
  • 15. Nelich A, Schleicher E. 1991. Immunohistochemical localization of extracellular matrix components in human diabetic glomerular lesions. Am J Pathol 139:889–899. [PMC free article] [PubMed] [Google Scholar]
  • 16. Falk RJ, Scheinman JI, Mauer SM, Michael AF. 1983. Polyantigenic expansion of basement membrane constituents in diabetic nephropathy. Diabetes 32(Suppl 2):34–39. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Laboratory Analysis are provided here courtesy of Wiley

RESOURCES